116 related articles for article (PubMed ID: 2553385)
1. Mechanism of erythropoietin action on the erythroid progenitor cells induced from murine erythroleukemia cells (TSA8).
Fukumoto H; Matsui Y; Obinata M
Development; 1989 Jan; 105(1):109-14. PubMed ID: 2553385
[TBL] [Abstract][Full Text] [Related]
2. Different signalling pathways are used in the commitment of murine erythroleukemia cells (TSA8) to differentiate, and in the erythropoietin action on progenitor cells.
Fukumoto H; Matsui Y; Obinata M
Cell Struct Funct; 1989 Apr; 14(2):231-9. PubMed ID: 2501036
[TBL] [Abstract][Full Text] [Related]
3. Factors controlling induction of commitment of murine erythroleukemia (TSA8) cells to CFU-E (colony forming unit-erythroid).
Noguchi T; Fukumoto H; Mishina Y; Obinata M
Development; 1987 Sep; 101(1):169-74. PubMed ID: 2835222
[TBL] [Abstract][Full Text] [Related]
4. Induction of commitment of murine erythroleukemia cells (TSA8) to CFU-E with DMSO.
Mishina Y; Obinata M
Exp Cell Res; 1986 Feb; 162(2):319-25. PubMed ID: 3455915
[TBL] [Abstract][Full Text] [Related]
5. Differentiation of erythroid progenitor (CFU-E) cells from mouse fetal liver cells and murine erythroleukemia (TSA8) cells without proliferation.
Noguchi T; Fukumoto H; Mishina Y; Obinata M
Mol Cell Biol; 1988 Jun; 8(6):2604-9. PubMed ID: 3165492
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin-induced differentiation of Rauscher erythroleukemia cells.
Sytkowski AJ; Perrine SP; Bicknell KA; Kessler CJ
Prog Clin Biol Res; 1983; 134():335-43. PubMed ID: 6320216
[TBL] [Abstract][Full Text] [Related]
7. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of theophylline and dibutyryl cAMP on murine erythroleukemia cell differentiation.
Sherman ML; Shafman TD; Kufe DW
Biochem Biophys Res Commun; 1986 Jan; 134(2):845-51. PubMed ID: 3004466
[TBL] [Abstract][Full Text] [Related]
9. Changes in G protein pattern and in G protein-dependent signaling during erythropoietin- and dimethylsulfoxide-induced differentiation of murine erythroleukemia cells.
Kesselring F; Spicher K; Porzig H
Blood; 1994 Dec; 84(12):4088-98. PubMed ID: 7994027
[TBL] [Abstract][Full Text] [Related]
10. The beta-adrenergic receptor adenylate cyclase complex of Rauscher murine erythroleukemia cells and its response to erythropoietin-induced differentiation.
Sytkowski AJ; Kessler CJ
Blood; 1984 Jul; 64(1):84-90. PubMed ID: 6329380
[TBL] [Abstract][Full Text] [Related]
11. [Factors controlling the differentiation and cancerization of murine erythroleukemia cells].
Obinata M
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 2):1989-95. PubMed ID: 3475040
[TBL] [Abstract][Full Text] [Related]
12. Transmembrane signaling during erythropoietin- and dimethylsulfoxide-induced erythroid cell differentiation.
Kuramochi S; Sugimoto Y; Ikawa Y; Todokoro K
Eur J Biochem; 1990 Oct; 193(1):163-8. PubMed ID: 2171931
[TBL] [Abstract][Full Text] [Related]
13. Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3.
O'Prey J; Leslie N; Itoh K; Ostertag W; Bartholomew C; Harrison PR
Blood; 1998 Mar; 91(5):1548-55. PubMed ID: 9473219
[TBL] [Abstract][Full Text] [Related]
14. Erythroid differentiation of clonal Rauscher erythroleukemia cells in response to erythropoietin or dimethyl sulfoxide.
Sytkowski AJ; Salvado AJ; Smith GM; McIntyre CJ; deBoth NJ
Science; 1980 Oct; 210(4465):74-6. PubMed ID: 6932101
[TBL] [Abstract][Full Text] [Related]
15. Stage-specific gene expression in erythroid progenitor cells (CFU-E).
Mishina Y; Matsui Y; Obinata M
Cell Differ; 1988 Feb; 22(3):259-65. PubMed ID: 3162713
[TBL] [Abstract][Full Text] [Related]
16. Combined inhibition of PI3K and activation of MAPK p38 signaling pathways trigger erythroid alternative splicing switch of 4.1R pre-mRNA in DMSO-induced erythroleukemia cells.
Breig O; Théoleyre-Schaal O; Baklouti F
Cell Signal; 2013 Dec; 25(12):2453-61. PubMed ID: 23993958
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
18. Mode of action of erythropoietin (Epo) in an Epo-dependent murine cell line. I. Involvement of adenosine 3',5'-cyclic monophosphate not as a second messenger but as a regulator of cell growth.
Tsuda H; Sawada T; Sakaguchi M; Kawakita M; Takatsuki K
Exp Hematol; 1989 Mar; 17(3):211-7. PubMed ID: 2465166
[TBL] [Abstract][Full Text] [Related]
19. Internalization of radioiodinated erythropoietin and the ligand-induced modulation of its receptor in murine erythroleukemia cells.
Fukamachi H; Tojo A; Saito T; Kitamura T; Nakata M; Urabe A; Takaku F
Int J Cell Cloning; 1987 May; 5(3):209-19. PubMed ID: 3474303
[TBL] [Abstract][Full Text] [Related]
20. Modulation of cyclic AMP levels and differentiation by adenosine analogs in mouse erythroleukemia cells.
Sherman ML; Shafman TD; Kufe DW
J Cell Physiol; 1988 Mar; 134(3):429-36. PubMed ID: 2450878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
